Effects of recombinant human erythropoietin on resistance artery endothelial function in stage 4 chronic kidney disease.

Journal of the American Heart Association

Volumn 2, Issue 2, 2013, Pages

  Briet, Marie ^a   Barhoumi, Tlili ^b   Mian, Muhammad Oneeb Rehman ^b   Sierra, Cristina ^b   Boutouyrie, Pierre ^b   Davidman, Michael ^b   Bercovitch, David ^b   Nessim, Sharon J ^b   Frisch, Gershon ^b   Paradis, Pierre ^b   Lipman, Mark L ^b   Schiffrin, Ernesto L ^b  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIANEMIC AGENT; ENDOTHELIN 1; ERYTHROPOIETIN; RECOMBINANT PROTEIN; VASODILATOR AGENT;

AGED; ANEMIA; ARTERIAL WALL THICKNESS; ARTERY; ARTICLE; BUTTOCK; CAROTID ARTERY; CHRONIC KIDNEY FAILURE; DRUG EFFECT; ECHOGRAPHY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PULSE WAVE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ACETYLCHOLINE; AGED; ANEMIA; ARTERIES; BUTTOCKS; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ERYTHROPOIETIN; FEMALE; HEMATINICS; HUMANS; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; RECOMBINANT PROTEINS; RENAL INSUFFICIENCY, CHRONIC; VASODILATOR AGENTS;

EID: 84884249540     PISSN: None     EISSN: 20479980     Source Type: None    
DOI: 10.1161/JAHA.113.000128     Document Type: Article

References (0)